BORTEZOMIB

BORTEZOMIB was reported 89993 times

BORTEZOMIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLASMA CELL MYELOMA REFRACTORY 765 0.5717
1 PRIMARY AMYLOIDOSIS 134 0.5214
2 PLASMA CELL MYELOMA RECURRENT 1268 0.3900
3 LEUKAEMIA PLASMACYTIC 57 0.3519
4 PLASMA CELL LEUKAEMIA 209 0.3483
5 PLASMACYTOMA 498 0.2673
6 BLOOD STEM CELL HARVEST FAILURE 39 0.2635
7 PLASMA CELL MYELOMA 9241 0.2366
8 LIGHT CHAIN DISEASE 34 0.2345
9 HYPERVISCOSITY SYNDROME 64 0.2222
10 AUTONOMIC NEUROPATHY 181 0.1787
11 IVTH NERVE PARALYSIS 42 0.1772
12 LIGHT CHAIN ANALYSIS INCREASED 179 0.1733
13 MONOCLONAL IMMUNOGLOBULIN INCREASED 49 0.1713
14 PLASMABLASTIC LYMPHOMA 57 0.1592
15 RENAL AMYLOIDOSIS 38 0.1551
16 B-CELL TYPE ACUTE LEUKAEMIA 110 0.1499
17 MULTIPLE MYELOMA 680 0.1458
18 MANTLE CELL LYMPHOMA 213 0.1399
19 MONOCLONAL IMMUNOGLOBULIN PRESENT 104 0.1368
20 AMYLOIDOSIS 230 0.1333
21 MORGANELLA INFECTION 35 0.1195
22 PARAPROTEINAEMIA 37 0.1194
23 CARDIAC AMYLOIDOSIS 128 0.1163
24 STEM CELL TRANSPLANT 288 0.1152
25 B PRECURSOR TYPE ACUTE LEUKAEMIA 44 0.1134
26 OSTEOLYSIS 199 0.0973
27 CHALAZION 61 0.0952
28 POLYNEUROPATHY 1098 0.0916
29 MONOCLONAL GAMMOPATHY 57 0.0909
30 PERIPHERAL SENSORIMOTOR NEUROPATHY 113 0.0899
31 ENGRAFTMENT SYNDROME 46 0.0778
32 MENINGITIS LISTERIA 39 0.0765
33 PERIPHERAL MOTOR NEUROPATHY 106 0.0756
34 HERPES ZOSTER DISSEMINATED 60 0.0747
35 PERIPHERAL SENSORY NEUROPATHY 434 0.0742
36 NEUROPATHY PERIPHERAL 6529 0.0686
37 PNEUMONIA PNEUMOCOCCAL 89 0.0601
38 NEUROPATHY 99 0.0582
39 BONE LESION 210 0.0582
40 OCULAR TOXICITY 63 0.0571
41 ACUTE LYMPHOCYTIC LEUKAEMIA 156 0.0550
42 METAPNEUMOVIRUS INFECTION 43 0.0548
43 GASTROINTESTINAL TOXICITY 261 0.0543
44 VISCERAL LEISHMANIASIS 39 0.0540
45 PNEUMOCOCCAL SEPSIS 35 0.0533
46 TUMOUR LYSIS SYNDROME 454 0.0515
47 INFECTION IN AN IMMUNOCOMPROMISED HOST 36 0.0501
48 ENTEROCOCCAL SEPSIS 39 0.0481
49 EMPYEMA 94 0.0472
50 DEVICE RELATED SEPSIS 95 0.0471
51 KERATOPATHY 73 0.0461
52 HEMIANOPIA 45 0.0454
53 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 38 0.0451
54 ILEUS PARALYTIC 200 0.0448
55 PNEUMONIA INFLUENZAL 52 0.0437
56 SKIN NEOPLASM EXCISION 34 0.0434
57 CYTOMEGALOVIRUS INFECTION REACTIVATION 190 0.0430
58 BONE MARROW TRANSPLANT 81 0.0427
59 CYTOPENIA 518 0.0423
60 FEBRILE INFECTION 49 0.0416
61 THERAPY PARTIAL RESPONDER 648 0.0415
62 TRANSPLANT 96 0.0404
63 KLEBSIELLA SEPSIS 45 0.0399
64 PATHOLOGICAL FRACTURE 201 0.0396
65 PROTEIN TOTAL INCREASED 105 0.0394
66 HYPOGAMMAGLOBULINAEMIA 259 0.0394
67 DEMYELINATING POLYNEUROPATHY 40 0.0389
68 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 89 0.0380
69 HAEMATOTOXICITY 360 0.0378
70 HYPERCALCAEMIA 466 0.0377
71 NEUTROPENIC INFECTION 36 0.0376
72 PARAINFLUENZAE VIRUS INFECTION 57 0.0374
73 STAPHYLOCOCCAL BACTERAEMIA 160 0.0368
74 SPINAL CORD COMPRESSION 142 0.0364
75 BLOOD IMMUNOGLOBULIN G INCREASED 44 0.0362
76 PSEUDOMONAL SEPSIS 63 0.0359
77 H1N1 INFLUENZA 50 0.0356
78 ENTEROCOCCAL INFECTION 169 0.0349
79 PNEUMOCYSTIS JIROVECII INFECTION 41 0.0343
80 THROMBOCYTOPENIA 3761 0.0336
81 ESCHERICHIA SEPSIS 97 0.0334
82 DIVERTICULAR PERFORATION 68 0.0330
83 ORTHOSTATIC HYPOTENSION 565 0.0324
84 NEUROGENIC BLADDER 68 0.0322
85 EXPOSED BONE IN JAW 69 0.0318
86 LISTERIOSIS 35 0.0316
87 HORDEOLUM 135 0.0312
88 PNEUMONIA CYTOMEGALOVIRAL 59 0.0303
89 GUILLAIN-BARRE SYNDROME 145 0.0299
90 HEPATITIS B REACTIVATION 95 0.0299
91 BACTERIAL SEPSIS 97 0.0298
92 ADENOCARCINOMA OF COLON 55 0.0293
93 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 41 0.0292
94 LOBAR PNEUMONIA 53 0.0286
95 PULMONARY SEPSIS 41 0.0282
96 MYELODYSPLASTIC SYNDROME 403 0.0278
97 NEOPLASM SKIN 43 0.0277
98 THROMBOTIC THROMBOCYTOPENIC PURPURA 97 0.0275
99 JC VIRUS INFECTION 44 0.0275
100 COMPRESSION FRACTURE 143 0.0267
101 IGA NEPHROPATHY 44 0.0265
102 PNEUMONIA FUNGAL 104 0.0263
103 CYSTITIS HAEMORRHAGIC 104 0.0258
104 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 245 0.0256
105 ADENOVIRUS INFECTION 73 0.0251
106 ESCHERICHIA BACTERAEMIA 59 0.0251
107 PANCYTOPENIA 1396 0.0250
108 CYTOMEGALOVIRUS VIRAEMIA 111 0.0249
109 FEBRILE BONE MARROW APLASIA 106 0.0249
110 KLEBSIELLA INFECTION 126 0.0249
111 CHRONIC GRAFT VERSUS HOST DISEASE 87 0.0241
112 HEPATITIS E 38 0.0241
113 BK VIRUS INFECTION 81 0.0240
114 PNEUMONIA KLEBSIELLA 44 0.0239
115 RHINOVIRUS INFECTION 93 0.0239
116 HEPATITIS B 143 0.0237
117 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 34 0.0236
118 PERIODONTITIS 51 0.0235
119 OSTEOSCLEROSIS 37 0.0235
120 SPINAL COMPRESSION FRACTURE 194 0.0234
121 BLEPHARITIS 94 0.0234
122 BACTERAEMIA 277 0.0233
123 LYMPHOPENIA 330 0.0233
124 AUTONOMIC NERVOUS SYSTEM IMBALANCE 68 0.0233
125 CYTOMEGALOVIRUS INFECTION 382 0.0230
126 NEUTROPENIC SEPSIS 164 0.0229
127 DISTURBANCE IN SOCIAL BEHAVIOUR 54 0.0229
128 VARICELLA ZOSTER VIRUS INFECTION 47 0.0227
129 NEUROTOXICITY 397 0.0226
130 HYPOPHOSPHATAEMIA 167 0.0226
131 CLOSTRIDIUM DIFFICILE COLITIS 239 0.0225
132 APLASIA 44 0.0224
133 SOFT TISSUE INFECTION 41 0.0224
134 SQUAMOUS CELL CARCINOMA OF SKIN 135 0.0223
135 BRONCHOPULMONARY ASPERGILLOSIS 173 0.0223
136 KYPHOSIS 39 0.0220
137 FEBRILE NEUTROPENIA 1443 0.0217
138 BLOOD CULTURE POSITIVE 65 0.0217
139 STAPHYLOCOCCAL SEPSIS 107 0.0217
140 SEPTIC SHOCK 937 0.0215
141 BONE MARROW FAILURE 431 0.0212
142 ACUTE GRAFT VERSUS HOST DISEASE 97 0.0212
143 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 172 0.0208
144 CAPILLARY LEAK SYNDROME 43 0.0208
145 DISEASE PROGRESSION 2458 0.0208
146 ACUTE MYELOID LEUKAEMIA 321 0.0206
147 ABDOMINAL ABSCESS 91 0.0206
148 PLATELET COUNT DECREASED 2194 0.0206
149 PNEUMONIA STAPHYLOCOCCAL 40 0.0203
150 NEUTROPENIA 2749 0.0202
151 THROMBOTIC MICROANGIOPATHY 197 0.0202
152 EMBOLISM VENOUS 60 0.0198
153 FULL BLOOD COUNT DECREASED 397 0.0197
154 HYPOALBUMINAEMIA 153 0.0197
155 CYTOMEGALOVIRUS TEST POSITIVE 35 0.0196
156 SECOND PRIMARY MALIGNANCY 163 0.0196
157 NOCARDIOSIS 50 0.0195
158 INTENTIONAL PRODUCT USE ISSUE 1712 0.0195
159 MENINGITIS CRYPTOCOCCAL 34 0.0194
160 NEUTROPENIC COLITIS 40 0.0193
161 ILEUS 240 0.0193
162 CYTOMEGALOVIRUS CHORIORETINITIS 37 0.0190
163 LUNG INFILTRATION 164 0.0185
164 PNEUMONIA VIRAL 59 0.0185
165 VARICELLA 44 0.0184
166 VENOUS THROMBOSIS LIMB 38 0.0184
167 FAILURE TO THRIVE 94 0.0181
168 OSTEITIS 45 0.0178
169 DERMATITIS EXFOLIATIVE GENERALISED 62 0.0178
170 OSTEONECROSIS OF JAW 441 0.0178
171 GRAFT VERSUS HOST DISEASE 126 0.0175
172 PSEUDOMEMBRANOUS COLITIS 39 0.0174
173 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 37 0.0174
174 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 40 0.0172
175 CARDIOTOXICITY 153 0.0171
176 ATRIAL FLUTTER 136 0.0170
177 VENOOCCLUSIVE LIVER DISEASE 84 0.0170
178 COVID-19 PNEUMONIA 199 0.0168
179 MUCOSAL INFLAMMATION 439 0.0168
180 ATELECTASIS 162 0.0167
181 PROTEIN TOTAL DECREASED 63 0.0167
182 LARGE INTESTINE PERFORATION 116 0.0167
183 PLEURITIC PAIN 46 0.0166
184 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 171 0.0166
185 CLOSTRIDIAL INFECTION 56 0.0165
186 OPTIC NEUROPATHY 35 0.0165
187 PERFORMANCE STATUS DECREASED 76 0.0163
188 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 419 0.0163
189 SEPSIS 1815 0.0163
190 BRAIN ABSCESS 41 0.0162
191 NEUTROPHIL COUNT DECREASED 658 0.0161
192 HERPES ZOSTER 927 0.0161
193 HYPOCALCAEMIA 305 0.0161
194 LUNG CONSOLIDATION 45 0.0161
195 BASAL CELL CARCINOMA 250 0.0160
196 NON-CARDIAC CHEST PAIN 50 0.0158
197 ACTINIC KERATOSIS 41 0.0158
198 DILATATION VENTRICULAR 33 0.0157
199 ERYSIPELAS 77 0.0153
200 PANNICULITIS 37 0.0153
201 PNEUMOCYSTIS JIROVECI PNEUMONIA 34 0.0152
202 PNEUMONIA BACTERIAL 140 0.0152
203 UROSEPSIS 140 0.0152
204 SYSTEMIC CANDIDA 38 0.0151
205 LUNG INFECTION 233 0.0150
206 ANAEMIA MACROCYTIC 32 0.0150
207 PNEUMOCYSTIS JIROVECII PNEUMONIA 150 0.0149
208 BRONCHOPNEUMONIA 50 0.0146
209 DIASTOLIC DYSFUNCTION 45 0.0146
210 EMBOLISM 121 0.0146
211 BONE MARROW DISORDER 44 0.0146
212 LEFT VENTRICULAR HYPERTROPHY 62 0.0145
213 ELECTROLYTE IMBALANCE 168 0.0144
214 ENTEROCOLITIS 83 0.0144
215 HICCUPS 118 0.0144
216 ASPERGILLUS INFECTION 94 0.0143
217 TOXIC SKIN ERUPTION 144 0.0143
218 DEEP VEIN THROMBOSIS 929 0.0143
219 ANAEMIA 2718 0.0142
220 CYTOKINE RELEASE SYNDROME 284 0.0141
221 HYPERURICAEMIA 58 0.0141
222 AORTIC ARTERIOSCLEROSIS 36 0.0140
223 ACUTE PULMONARY OEDEMA 78 0.0139
224 RESPIRATORY TRACT INFECTION 361 0.0138
225 VENOUS THROMBOSIS 54 0.0137
226 TRANSPLANT REJECTION 110 0.0137
227 PULMONARY ALVEOLAR HAEMORRHAGE 77 0.0137
228 CARDIAC FAILURE ACUTE 91 0.0136
229 ORAL INTAKE REDUCED 33 0.0136
230 THERAPY NON-RESPONDER 610 0.0136
231 URINARY TRACT INFECTION BACTERIAL 34 0.0134
232 ACUTE RESPIRATORY DISTRESS SYNDROME 237 0.0134
233 METABOLIC ENCEPHALOPATHY 40 0.0133
234 BLOOD LACTATE DEHYDROGENASE INCREASED 210 0.0132
235 MULTIPLE ORGAN DYSFUNCTION SYNDROME 374 0.0132
236 SUDDEN CARDIAC DEATH 45 0.0132
237 DRUG TOLERANCE DECREASED 37 0.0132
238 HUMERUS FRACTURE 63 0.0131
239 MYELOSUPPRESSION 467 0.0130
240 BONE DISORDER 236 0.0129
241 CANCER PAIN 33 0.0129
242 INFUSION RELATED REACTION 854 0.0129
243 SQUAMOUS CELL CARCINOMA 121 0.0128
244 WHITE BLOOD CELL COUNT DECREASED 1390 0.0128
245 RASH MACULO-PAPULAR 285 0.0128
246 ESCHERICHIA INFECTION 105 0.0128
247 LABORATORY TEST ABNORMAL 376 0.0127
248 ESCHERICHIA URINARY TRACT INFECTION 54 0.0127
249 PNEUMONIA 4108 0.0127
250 LEFT VENTRICULAR DYSFUNCTION 84 0.0125
251 THORACIC VERTEBRAL FRACTURE 37 0.0125
252 LEUKOPENIA 622 0.0124
253 CARDIAC FAILURE 991 0.0123
254 VASCULAR DEVICE INFECTION 56 0.0123
255 LUMBAR VERTEBRAL FRACTURE 56 0.0122
256 CARDIOMYOPATHY 180 0.0122
257 SKIN NECROSIS 63 0.0121
258 LEUKOENCEPHALOPATHY 45 0.0121
259 CLOSTRIDIUM DIFFICILE INFECTION 261 0.0119
260 HYPOKALAEMIA 549 0.0119
261 NEURALGIA 289 0.0119
262 PLEURAL EFFUSION 722 0.0119
263 MULTI-ORGAN FAILURE 204 0.0118
264 PULMONARY HAEMORRHAGE 92 0.0117
265 ORGANISING PNEUMONIA 58 0.0117
266 LUMBAR SPINAL STENOSIS 34 0.0116
267 SUDDEN DEATH 123 0.0116
268 SPINAL OSTEOARTHRITIS 102 0.0116
269 ATRIAL FIBRILLATION 1122 0.0115
270 CONGESTIVE CARDIOMYOPATHY 48 0.0115
271 GASTROINTESTINAL INFLAMMATION 90 0.0115
272 CANDIDA INFECTION 194 0.0115
273 NO THERAPEUTIC RESPONSE 139 0.0114
274 INFECTION 1648 0.0114
275 BRONCHIOLITIS 40 0.0114
276 LEFT VENTRICULAR FAILURE 39 0.0113
277 GINGIVITIS 61 0.0113
278 DEAFNESS NEUROSENSORY 37 0.0112
279 MYOPATHY 97 0.0112
280 GENERALISED OEDEMA 138 0.0111
281 OLIGURIA 69 0.0111
282 ATYPICAL PNEUMONIA 33 0.0110
283 PSEUDOMONAS INFECTION 94 0.0110
284 TRICUSPID VALVE INCOMPETENCE 87 0.0109
285 ENDOCARDITIS 56 0.0109
286 CACHEXIA 56 0.0109
287 HERPES SIMPLEX 70 0.0108
288 HYPERVOLAEMIA 53 0.0107
289 SMALL INTESTINAL OBSTRUCTION 132 0.0107
290 BRAIN NATRIURETIC PEPTIDE INCREASED 33 0.0107
291 ORTHOPNOEA 34 0.0107
292 BLOOD CALCIUM DECREASED 120 0.0107
293 RENAL FAILURE ACUTE 451 0.0106
294 RESPIRATORY FAILURE 775 0.0106
295 CARDIOMEGALY 130 0.0106
296 LOOSE TOOTH 34 0.0105
297 IMMUNOSUPPRESSION 93 0.0105
298 UPPER RESPIRATORY TRACT INFECTION 486 0.0105
299 TROPONIN INCREASED 80 0.0105
300 MITRAL VALVE INCOMPETENCE 119 0.0105
301 HYPOXIA 370 0.0105
302 BLOOD CALCIUM INCREASED 92 0.0105
303 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 40 0.0105
304 BACTERIAL INFECTION 195 0.0104
305 RESPIRATORY SYNCYTIAL VIRUS INFECTION 91 0.0104
306 MALNUTRITION 116 0.0104
307 APLASTIC ANAEMIA 54 0.0103
308 ABSCESS LIMB 44 0.0103
309 COLITIS 390 0.0103
310 NEOPLASM 118 0.0103
311 CLAVICLE FRACTURE 39 0.0102
312 PULMONARY TOXICITY 72 0.0102
313 ENTERITIS 65 0.0101
314 CONSTIPATION 2208 0.0101
315 BLOOD DISORDER 81 0.0101
316 DEVICE RELATED INFECTION 155 0.0101
317 HYPERGLYCAEMIA 366 0.0100
318 PERONEAL NERVE PALSY 57 0.0100
319 MUSCULOSKELETAL CHEST PAIN 155 0.0100
320 HAEMOGLOBIN DECREASED 1027 0.0100
321 THROMBOPHLEBITIS 35 0.0100
322 GASTROINTESTINAL INFECTION 89 0.0099
323 RENAL FAILURE CHRONIC 76 0.0099
324 MENINGITIS 66 0.0099
325 APLASIA PURE RED CELL 34 0.0099
326 RIB FRACTURE 203 0.0099
327 PNEUMONITIS 266 0.0098
328 PAPILLOEDEMA 44 0.0097
329 BREATH SOUNDS ABNORMAL 48 0.0097
330 ACUTE RESPIRATORY FAILURE 186 0.0097
331 DISSEMINATED INTRAVASCULAR COAGULATION 136 0.0097
332 DRUG RESISTANCE 248 0.0096
333 DECUBITUS ULCER 78 0.0096
334 BLOOD CREATININE INCREASED 623 0.0095
335 EJECTION FRACTION DECREASED 148 0.0095
336 AMYLASE INCREASED 35 0.0095
337 NEPHROTIC SYNDROME 65 0.0095
338 NEUROLOGICAL SYMPTOM 54 0.0094
339 GENERAL PHYSICAL CONDITION ABNORMAL 64 0.0094
340 INTERVERTEBRAL DISC DISORDER 40 0.0094
341 SINUS TACHYCARDIA 133 0.0094
342 DEHYDRATION 1244 0.0093
343 OESOPHAGEAL CANDIDIASIS 37 0.0093
344 OSTEOMYELITIS 168 0.0093
345 HYPONATRAEMIA 522 0.0093
346 AZOTAEMIA 37 0.0093
347 AGEUSIA 231 0.0093
348 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 69 0.0092
349 AORTIC STENOSIS 32 0.0092
350 PULMONARY OEDEMA 411 0.0092
351 RED BLOOD CELL COUNT DECREASED 261 0.0091
352 PULMONARY FIBROSIS 175 0.0091
353 SPINAL COLUMN STENOSIS 43 0.0091
354 RENAL FAILURE 1205 0.0091
355 RENAL TUBULAR NECROSIS 89 0.0091
356 HYPOVOLAEMIA 53 0.0090
357 HEPATOTOXICITY 201 0.0090
358 SKIN TOXICITY 51 0.0090
359 CELLULITIS 453 0.0090
360 HAEMATOCRIT DECREASED 178 0.0090
361 KIDNEY TRANSPLANT REJECTION 43 0.0090
362 DRUG TOLERANCE 45 0.0089
363 PYELONEPHRITIS 77 0.0089
364 DRUG ERUPTION 157 0.0089
365 HYPERTRANSAMINASAEMIA 61 0.0088
366 AORTIC VALVE INCOMPETENCE 37 0.0087
367 TASTE DISORDER 176 0.0087
368 ENCEPHALITIS 60 0.0087
369 SUPRAVENTRICULAR TACHYCARDIA 83 0.0087
370 THROMBOSIS 695 0.0086
371 SPINAL FRACTURE 173 0.0086
372 BLOOD POTASSIUM DECREASED 259 0.0086
373 PULMONARY EMBOLISM 815 0.0086
374 BLOOD ALBUMIN DECREASED 68 0.0086
375 BONE PAIN 502 0.0086
376 INTESTINAL ISCHAEMIA 47 0.0085
377 UNEVALUABLE EVENT 645 0.0085
378 HYPERPYREXIA 36 0.0085
379 BLOOD URIC ACID INCREASED 49 0.0085
380 OEDEMA PERIPHERAL 1032 0.0085
381 NEPHROPATHY 79 0.0085
382 ORAL DISORDER 62 0.0084
383 ACUTE CORONARY SYNDROME 70 0.0084
384 PYREXIA 2898 0.0084
385 PROTEINURIA 159 0.0084
386 RENAL IMPAIRMENT 695 0.0083
387 HAEMORRHOIDAL HAEMORRHAGE 40 0.0082
388 FLUID OVERLOAD 119 0.0082
389 MYOCARDITIS 93 0.0081
390 DIARRHOEA 5237 0.0081
391 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 63 0.0081
392 ENCEPHALOPATHY 199 0.0081
393 FLANK PAIN 75 0.0080
394 FEMORAL NECK FRACTURE 41 0.0080
395 BLOOD MAGNESIUM DECREASED 69 0.0080
396 HYPERTHERMIA 61 0.0080
397 CEREBRAL ISCHAEMIA 41 0.0080
398 ACUTE KIDNEY INJURY 1218 0.0080
399 EOSINOPHILIA 139 0.0079
400 NECROSIS 44 0.0079
401 ANURIA 68 0.0079
402 RESPIRATORY DISTRESS 218 0.0079
403 PERIORBITAL OEDEMA 41 0.0079
404 INTERVERTEBRAL DISC DEGENERATION 73 0.0079
405 INTERSTITIAL LUNG DISEASE 381 0.0079
406 PROTHROMBIN TIME PROLONGED 47 0.0079
407 TOOTH DISORDER 173 0.0078
408 CHOLECYSTITIS ACUTE 44 0.0078
409 BLOOD UREA INCREASED 130 0.0078
410 DIVERTICULITIS 215 0.0078
411 INTESTINAL PERFORATION 87 0.0077
412 CARDIOGENIC SHOCK 111 0.0077
413 LUNG DISORDER 379 0.0077
414 ECCHYMOSIS 53 0.0077
415 PULMONARY HYPERTENSION 161 0.0077
416 PURULENT DISCHARGE 33 0.0077
417 MENTAL STATUS CHANGES 214 0.0077
418 LYMPHOCYTE COUNT DECREASED 136 0.0077
419 SYNCOPE 763 0.0076
420 BUNDLE BRANCH BLOCK RIGHT 35 0.0076
421 HYPERAMMONAEMIA 38 0.0076
422 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 45 0.0076
423 MALIGNANT NEOPLASM PROGRESSION 776 0.0076
424 VIRAL UPPER RESPIRATORY TRACT INFECTION 36 0.0076
425 HYPOTENSION 1519 0.0076
426 ANOREXIA 97 0.0075
427 STAPHYLOCOCCAL INFECTION 248 0.0075
428 OESOPHAGITIS 82 0.0075
429 HAEMODIALYSIS 63 0.0075
430 DIALYSIS 106 0.0075
431 HERPES VIRUS INFECTION 43 0.0075
432 OFF LABEL USE 6498 0.0074
433 BLOOD SODIUM DECREASED 139 0.0074
434 PURPURA 65 0.0073
435 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 37 0.0073
436 OEDEMA 393 0.0072
437 STREPTOCOCCAL INFECTION 40 0.0072
438 HYPOMAGNESAEMIA 100 0.0072
439 RENAL CYST 57 0.0072
440 C-REACTIVE PROTEIN INCREASED 260 0.0071
441 COLITIS ISCHAEMIC 48 0.0071
442 HYPOVOLAEMIC SHOCK 34 0.0071
443 CARDIAC FAILURE CONGESTIVE 570 0.0071
444 HYPERNATRAEMIA 35 0.0070
445 GASTROENTERITIS 102 0.0070
446 HAEMODYNAMIC INSTABILITY 53 0.0069
447 SPLENOMEGALY 81 0.0069
448 DIVERTICULUM 49 0.0069
449 ISCHAEMIC STROKE 123 0.0069
450 TOXICITY TO VARIOUS AGENTS 1162 0.0069
451 BRAIN OEDEMA 87 0.0069
452 FAECAL INCONTINENCE 33 0.0069
453 SEASONAL ALLERGY 97 0.0068
454 BODY HEIGHT DECREASED 73 0.0068
455 PETECHIAE 71 0.0068
456 RASH PRURITIC 368 0.0068
457 PULMONARY THROMBOSIS 74 0.0068
458 NEPHROPATHY TOXIC 76 0.0068
459 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 371 0.0068
460 EPSTEIN-BARR VIRUS INFECTION 42 0.0067
461 LOWER RESPIRATORY TRACT INFECTION 304 0.0067
462 TOOTH ABSCESS 68 0.0067
463 ACIDOSIS 51 0.0067
464 MULTIPLE ALLERGIES 52 0.0066
465 OSTEONECROSIS 217 0.0066
466 HAEMOLYSIS 51 0.0066
467 HEPATOMEGALY 64 0.0065
468 DRUG INTOLERANCE 627 0.0065
469 PERICARDIAL EFFUSION 150 0.0065
470 APPENDICITIS 60 0.0064
471 RIGHT VENTRICULAR FAILURE 45 0.0064
472 HYPERKALAEMIA 225 0.0064
473 MYOCARDIAL ISCHAEMIA 73 0.0064
474 EYE INFECTION 72 0.0064
475 ASPARTATE AMINOTRANSFERASE INCREASED 338 0.0064
476 SHOCK 146 0.0063
477 GENERAL PHYSICAL HEALTH DETERIORATION 734 0.0063
478 HYPOPHAGIA 162 0.0063
479 PARTIAL SEIZURES 33 0.0063
480 HEPATOCELLULAR INJURY 89 0.0063
481 VASCULITIS 73 0.0063
482 LEUKAEMIA 59 0.0062
483 DECREASED APPETITE 1449 0.0062
484 ORAL CANDIDIASIS 82 0.0062
485 HYPOAESTHESIA 931 0.0062
486 ARTERIOSCLEROSIS CORONARY ARTERY 41 0.0062
487 WRONG DRUG ADMINISTERED 55 0.0062
488 GOUT 110 0.0061
489 CHOLECYSTITIS 73 0.0061
490 ATRIOVENTRICULAR BLOCK COMPLETE 41 0.0061
491 INGUINAL HERNIA 37 0.0061
492 BLOOD ALKALINE PHOSPHATASE INCREASED 151 0.0061
493 AGRANULOCYTOSIS 113 0.0061
494 URINE OUTPUT DECREASED 53 0.0061
495 SPINAL PAIN 71 0.0061
496 ARRHYTHMIA 284 0.0060
497 RASH GENERALISED 155 0.0060
498 PRODUCT USE ISSUE 1124 0.0060
499 THERAPEUTIC RESPONSE DECREASED 362 0.0060
500 LEUKOCYTOSIS 108 0.0060
501 TACHYPNOEA 81 0.0060
502 PLATELET COUNT ABNORMAL 36 0.0059
503 EMPHYSEMA 60 0.0059
504 SUBDURAL HAEMATOMA 85 0.0059
505 ASTHENIA 2230 0.0059
506 SPINAL DISORDER 56 0.0059
507 FATIGUE 4581 0.0059
508 PRODUCT USE IN UNAPPROVED INDICATION 1456 0.0059
509 TOOTH EXTRACTION 73 0.0059
510 DIFFUSE LARGE B-CELL LYMPHOMA 45 0.0058
511 GASTROINTESTINAL DISORDER 522 0.0058
512 DISEASE RECURRENCE 277 0.0058
513 MALIGNANT MELANOMA 78 0.0058
514 COAGULOPATHY 97 0.0058
515 HEPATIC FUNCTION ABNORMAL 217 0.0058
516 HYPERTRIGLYCERIDAEMIA 34 0.0058
517 TRANSAMINASES INCREASED 129 0.0058
518 DRUG TOXICITY 79 0.0058
519 THERAPY CHANGE 57 0.0058
520 ERYTHEMA MULTIFORME 54 0.0058
521 BLOOD POTASSIUM INCREASED 94 0.0058
522 HAEMOGLOBIN ABNORMAL 37 0.0057
523 ALANINE AMINOTRANSFERASE INCREASED 353 0.0057
524 HEPATIC FAILURE 173 0.0057
525 PAIN IN JAW 162 0.0057
526 RHEUMATOID FACTOR POSITIVE 33 0.0057
527 COVID-19 1000 0.0057
528 DENTAL CARIES 63 0.0057
529 DELIRIUM 197 0.0057
530 STRESS CARDIOMYOPATHY 33 0.0057
531 BLOOD COUNT ABNORMAL 86 0.0057
532 RASH 2472 0.0057
533 DIARRHOEA HAEMORRHAGIC 53 0.0057
534 NERVE INJURY 63 0.0057
535 SINUS BRADYCARDIA 54 0.0056
536 VENTRICULAR EXTRASYSTOLES 58 0.0056
537 RENAL DISORDER 259 0.0056
538 BLOOD BILIRUBIN INCREASED 150 0.0055
539 ANGINA UNSTABLE 36 0.0055
540 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 394 0.0055
541 PULMONARY CONGESTION 73 0.0055
542 PAPULE 39 0.0055
543 PARAESTHESIA 867 0.0055
544 NERVOUS SYSTEM DISORDER 172 0.0055
545 ACUTE MYOCARDIAL INFARCTION 162 0.0055
546 RASH PUSTULAR 40 0.0055
547 ADVERSE DRUG REACTION 493 0.0055
548 SKIN REACTION 77 0.0055
549 SENSORY LOSS 44 0.0055
550 URINARY TRACT INFECTION 930 0.0054
551 VIRAL INFECTION 181 0.0054
552 ADRENAL INSUFFICIENCY 66 0.0054
553 END STAGE RENAL DISEASE 99 0.0054
554 ALTERED STATE OF CONSCIOUSNESS 117 0.0054
555 BRONCHOSPASM 77 0.0054
556 TENDERNESS 56 0.0054
557 MUSCLE ATROPHY 68 0.0054
558 HAEMOLYTIC ANAEMIA 48 0.0054
559 PRESYNCOPE 129 0.0053
560 HAEMORRHOIDS 103 0.0053
561 CEREBRAL INFARCTION 129 0.0053
562 IMMUNODEFICIENCY 78 0.0052
563 SKIN ULCER 135 0.0052
564 RHINITIS 42 0.0052
565 PERIPHERAL SWELLING 799 0.0052
566 PNEUMONIA ASPIRATION 129 0.0052
567 FACIAL PARALYSIS 44 0.0052
568 PANCREATITIS ACUTE 116 0.0052
569 DIZZINESS POSTURAL 50 0.0052
570 BRONCHITIS 381 0.0051
571 C-REACTIVE PROTEIN ABNORMAL 33 0.0051
572 CATARACT 306 0.0051
573 URINARY RETENTION 171 0.0051
574 CEREBRAL HAEMORRHAGE 182 0.0051
575 TOOTH INFECTION 67 0.0051
576 JOINT EFFUSION 35 0.0051
577 BACK PAIN 1179 0.0051
578 ATAXIA 60 0.0051
579 VENTRICULAR TACHYCARDIA 83 0.0050
580 CHILLS 589 0.0050
581 HEPATIC CYTOLYSIS 64 0.0050
582 HAEMOPTYSIS 140 0.0050
583 DYSPNOEA EXERTIONAL 189 0.0050
584 MASS 70 0.0050
585 INCREASED TENDENCY TO BRUISE 46 0.0050
586 PHARYNGITIS 62 0.0050
587 NEUTROPHIL COUNT INCREASED 51 0.0050
588 LIVER DISORDER 220 0.0050
589 CONJUNCTIVITIS 92 0.0050
590 CIRCULATORY COLLAPSE 84 0.0049
591 DERMATITIS ALLERGIC 62 0.0049
592 DEATH 4220 0.0049
593 ARTERIOSCLEROSIS 46 0.0049
594 TUBULOINTERSTITIAL NEPHRITIS 91 0.0049
595 CHOLESTASIS 93 0.0048
596 ELECTROCARDIOGRAM QT PROLONGED 174 0.0048
597 LIPASE INCREASED 37 0.0048
598 CONFUSIONAL STATE 780 0.0048
599 MUSCULAR WEAKNESS 548 0.0048
600 SUBARACHNOID HAEMORRHAGE 49 0.0048
601 FUNGAL INFECTION 160 0.0048
602 ATRIOVENTRICULAR BLOCK 37 0.0048
603 CARDIAC ARREST 394 0.0048
604 LYMPHOEDEMA 33 0.0048
605 FLUID RETENTION 242 0.0048
606 ASPIRATION 52 0.0047
607 NEOPLASM PROGRESSION 165 0.0047
608 EYELID OEDEMA 55 0.0047
609 LIVER FUNCTION TEST ABNORMAL 136 0.0047
610 TOXIC EPIDERMAL NECROLYSIS 71 0.0047
611 INFLUENZA 519 0.0046
612 GENERALISED TONIC-CLONIC SEIZURE 77 0.0046
613 SKIN INFECTION 52 0.0046
614 PULMONARY MASS 69 0.0046
615 HAEMORRHAGE INTRACRANIAL 69 0.0046
616 VENTRICULAR FIBRILLATION 51 0.0046
617 ULCER 73 0.0046
618 PERIPHERAL COLDNESS 63 0.0046
619 PERITONITIS 95 0.0046
620 HYDRONEPHROSIS 34 0.0045
621 HEPATITIS 116 0.0045
622 GASTROINTESTINAL HAEMORRHAGE 378 0.0045
623 SKIN LESION 124 0.0045
624 MOUTH HAEMORRHAGE 33 0.0045
625 EXOSTOSIS 41 0.0045
626 TOOTHACHE 81 0.0045
627 TOOTH FRACTURE 49 0.0044
628 HYPERBILIRUBINAEMIA 46 0.0044
629 DERMATITIS 93 0.0044
630 STOMATITIS 269 0.0044
631 HYPERLIPIDAEMIA 53 0.0044
632 BLOOD TEST ABNORMAL 62 0.0044
633 IMMUNE SYSTEM DISORDER 58 0.0044
634 ADVERSE EVENT 405 0.0044
635 DISORIENTATION 174 0.0044
636 ASCITES 129 0.0044
637 GAMMA-GLUTAMYLTRANSFERASE INCREASED 97 0.0044
638 BODY TEMPERATURE INCREASED 89 0.0044
639 ORAL PAIN 97 0.0043
640 ADVERSE REACTION 57 0.0043
641 CARDIOVASCULAR DISORDER 109 0.0043
642 CORONARY ARTERY DISEASE 130 0.0043
643 UPPER GASTROINTESTINAL HAEMORRHAGE 72 0.0043
644 INTESTINAL OBSTRUCTION 161 0.0043
645 WEIGHT DECREASED 1190 0.0043
646 INTERVERTEBRAL DISC PROTRUSION 93 0.0043
647 MELAENA 93 0.0042
648 HAEMATOMA 109 0.0042
649 EYE INFLAMMATION 40 0.0042
650 DYSGEUSIA 311 0.0042
651 EPISTAXIS 313 0.0042
652 HIATUS HERNIA 54 0.0042
653 RESPIRATORY RATE INCREASED 37 0.0042
654 SARS-COV-2 TEST POSITIVE 55 0.0042
655 INCONTINENCE 44 0.0042
656 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 217 0.0042
657 METASTASES TO BONE 68 0.0041
658 HAEMATURIA 141 0.0041
659 INJECTION SITE RASH 125 0.0041
660 PRODUCTIVE COUGH 194 0.0041
661 RESPIRATORY DISORDER 121 0.0040
662 MUSCLE SPASMS 740 0.0040
663 FRACTURE 76 0.0040
664 COGNITIVE DISORDER 187 0.0040
665 METABOLIC ACIDOSIS 128 0.0040
666 TRANSIENT ISCHAEMIC ATTACK 135 0.0040
667 RASH ERYTHEMATOUS 190 0.0040
668 PNEUMOTHORAX 63 0.0040
669 INTERNATIONAL NORMALISED RATIO INCREASED 113 0.0040
670 RECTAL HAEMORRHAGE 170 0.0040
671 NAUSEA 3129 0.0039
672 CARDIO-RESPIRATORY ARREST 165 0.0039
673 PULMONARY ARTERIAL HYPERTENSION 57 0.0039
674 TREATMENT FAILURE 322 0.0039
675 RED BLOOD CELL SEDIMENTATION RATE INCREASED 43 0.0039
676 VOMITING 1825 0.0039
677 GASTRITIS 102 0.0039
678 BURSITIS 47 0.0039
679 NOCTURIA 47 0.0039
680 COLON CANCER 57 0.0038
681 TRANSFUSION 40 0.0038
682 DEAFNESS 99 0.0038
683 MYOCLONUS 45 0.0038
684 PANCREATITIS 199 0.0038
685 CARDIAC DISORDER 352 0.0038
686 ABSCESS 60 0.0038
687 LYMPHOMA 58 0.0037
688 LETHARGY 215 0.0037
689 CYSTITIS 119 0.0037
690 GASTRIC ULCER 71 0.0037
691 DYSPNOEA 2111 0.0037
692 LOCALISED INFECTION 90 0.0037
693 HYPOTONIA 37 0.0037
694 VISUAL ACUITY REDUCED 123 0.0037
695 ANGINA PECTORIS 106 0.0037
696 OSTEOPENIA 56 0.0037
697 FALL 1228 0.0037
698 SKIN DISCOLOURATION 169 0.0037
699 HIP FRACTURE 118 0.0037
700 HEPATITIS C 44 0.0036
701 ABDOMINAL DISTENSION 380 0.0036
702 DEFORMITY 34 0.0036
703 WEIGHT FLUCTUATION 38 0.0036
704 BLADDER DISORDER 36 0.0036
705 DIPLOPIA 94 0.0036
706 INJECTION SITE DISCOLOURATION 45 0.0036
707 BRADYCARDIA 191 0.0036
708 ACUTE HEPATIC FAILURE 49 0.0036
709 PERICARDITIS 60 0.0036
710 TACHYCARDIA 317 0.0036
711 GASTRIC HAEMORRHAGE 41 0.0036
712 ABASIA 88 0.0036
713 WOUND INFECTION 39 0.0036
714 NIGHT SWEATS 114 0.0035
715 HEPATIC ENZYME INCREASED 241 0.0035
716 FEMUR FRACTURE 109 0.0035
717 FACE OEDEMA 59 0.0035
718 OXYGEN SATURATION DECREASED 196 0.0035
719 ABDOMINAL PAIN 807 0.0035
720 GINGIVAL BLEEDING 47 0.0034
721 IMPAIRED HEALING 113 0.0034
722 HAEMATEMESIS 87 0.0034
723 CHEST PAIN 628 0.0034
724 INJECTION SITE REACTION 233 0.0034
725 SINUS DISORDER 67 0.0034
726 ROTATOR CUFF SYNDROME 43 0.0033
727 DEPRESSED LEVEL OF CONSCIOUSNESS 132 0.0033
728 LIMB DISCOMFORT 103 0.0033
729 STEVENS-JOHNSON SYNDROME 74 0.0033
730 BLOOD PRESSURE DECREASED 219 0.0033
731 BLOOD IRON DECREASED 39 0.0033
732 INSOMNIA 873 0.0033
733 PARAESTHESIA ORAL 47 0.0033
734 BALANCE DISORDER 281 0.0032
735 HYPOAESTHESIA ORAL 49 0.0032
736 HEMIPARESIS 55 0.0032
737 MUSCULOSKELETAL PAIN 170 0.0032
738 HYPERTENSIVE CRISIS 36 0.0032
739 INFLAMMATION 167 0.0032
740 SWELLING FACE 210 0.0032
741 FULL BLOOD COUNT ABNORMAL 34 0.0032
742 RESPIRATORY TRACT CONGESTION 51 0.0032
743 PARANOIA 55 0.0032
744 STATUS EPILEPTICUS 36 0.0032
745 TINNITUS 146 0.0032
746 TREMOR 527 0.0032
747 LYMPHADENOPATHY 112 0.0032
748 JOINT SWELLING 381 0.0032
749 DYSURIA 116 0.0031
750 BLOOD PRESSURE ABNORMAL 62 0.0031
751 HOSPITALISATION 478 0.0031
752 VISION BLURRED 426 0.0031
753 DIZZINESS 1546 0.0031
754 HAEMORRHAGE 324 0.0031
755 LACRIMATION INCREASED 93 0.0031
756 BACK DISORDER 50 0.0031
757 EPILEPSY 94 0.0031
758 LIVER FUNCTION TEST INCREASED 66 0.0031
759 SINUSITIS 315 0.0031
760 INJECTION SITE IRRITATION 39 0.0031
761 UPPER LIMB FRACTURE 61 0.0031
762 HEPATIC STEATOSIS 57 0.0031
763 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 71 0.0030
764 SKIN DISORDER 101 0.0030
765 HYPERTENSION 640 0.0030
766 DEMENTIA 84 0.0030
767 OSTEOARTHRITIS 127 0.0030
768 GASTRIC DISORDER 102 0.0030
769 DYSPHAGIA 280 0.0029
770 EAR PAIN 57 0.0029
771 REBOUND EFFECT 33 0.0029
772 COUGH 817 0.0029
773 PAIN IN EXTREMITY 857 0.0029
774 URINARY INCONTINENCE 86 0.0029
775 CYST 36 0.0029
776 DRUG INEFFECTIVE 3816 0.0029
777 DRY EYE 144 0.0029
778 LOSS OF CONSCIOUSNESS 368 0.0029
779 JAUNDICE 77 0.0029
780 PRESCRIBED UNDERDOSE 57 0.0029
781 HEAD INJURY 90 0.0028
782 INCREASED APPETITE 54 0.0028
783 GASTROENTERITIS VIRAL 51 0.0028
784 SCIATICA 45 0.0028
785 WHITE BLOOD CELL COUNT INCREASED 108 0.0028
786 FEEDING DISORDER 57 0.0028
787 RESTLESS LEGS SYNDROME 51 0.0028
788 EYE SWELLING 103 0.0028
789 GLOMERULAR FILTRATION RATE DECREASED 34 0.0028
790 TREATMENT NONCOMPLIANCE 151 0.0028
791 MOUTH ULCERATION 58 0.0027
792 TOOTH LOSS 57 0.0027
793 BRAIN FOG 43 0.0027
794 INJECTION SITE ERYTHEMA 340 0.0027
795 SKIN CANCER 59 0.0027
796 SINUS CONGESTION 37 0.0027
797 LIVER INJURY 67 0.0027
798 WOUND 76 0.0027
799 NO ADVERSE EVENT 492 0.0027
800 UNRESPONSIVE TO STIMULI 70 0.0027
801 POLLAKIURIA 113 0.0027
802 CYANOSIS 42 0.0027
803 DYSPHONIA 156 0.0027
804 ARTHROPATHY 148 0.0027
805 FLATULENCE 151 0.0027
806 DIABETES MELLITUS 202 0.0026
807 GLAUCOMA 51 0.0026
808 NASOPHARYNGITIS 488 0.0026
809 RHINORRHOEA 171 0.0026
810 CONTUSION 253 0.0026
811 DYSPEPSIA 258 0.0026
812 RASH MACULAR 90 0.0026
813 DRUG-INDUCED LIVER INJURY 80 0.0025
814 BEDRIDDEN 33 0.0025
815 ORAL HERPES 49 0.0025
816 THERAPEUTIC PRODUCT EFFECT DECREASED 112 0.0025
817 GASTROOESOPHAGEAL REFLUX DISEASE 201 0.0025
818 HYPOGLYCAEMIA 121 0.0025
819 HYPERSOMNIA 71 0.0025
820 GALLBLADDER DISORDER 44 0.0025
821 COMA 115 0.0024
822 OSTEOPOROSIS 99 0.0024
823 EATING DISORDER 51 0.0024
824 METASTASES TO LIVER 42 0.0024
825 ERECTILE DYSFUNCTION 61 0.0024
826 PARALYSIS 34 0.0024
827 DYSSTASIA 69 0.0024
828 AGITATION 173 0.0024
829 SYNOVITIS 42 0.0023
830 SKIN EXFOLIATION 194 0.0023
831 LOCAL SWELLING 40 0.0023
832 NECK PAIN 128 0.0023
833 CONDITION AGGRAVATED 696 0.0023
834 HEPATIC CIRRHOSIS 43 0.0023
835 MYOCARDIAL INFARCTION 399 0.0023
836 SWELLING 214 0.0023
837 HYPOACUSIS 98 0.0023
838 ARTHRITIS 179 0.0023
839 MOOD ALTERED 62 0.0023
840 MUSCULOSKELETAL DISCOMFORT 39 0.0023
841 MANIA 37 0.0022
842 GAIT INABILITY 75 0.0022
843 RASH PAPULAR 50 0.0022
844 DRUG EFFECT INCOMPLETE 81 0.0022
845 MALAISE 978 0.0022
846 CHOLELITHIASIS 73 0.0022
847 EYE DISORDER 73 0.0022
848 EAR INFECTION 59 0.0022
849 CEREBROVASCULAR ACCIDENT 374 0.0022
850 PRODUCT PRESCRIBING ISSUE 48 0.0022
851 ABNORMAL BEHAVIOUR 87 0.0022
852 PRODUCT DOSE OMISSION 143 0.0022
853 HAEMATOCHEZIA 120 0.0022
854 ABDOMINAL DISCOMFORT 364 0.0022
855 SLEEP APNOEA SYNDROME 41 0.0021
856 PRURITUS 823 0.0021
857 GAIT DISTURBANCE 409 0.0021
858 ABDOMINAL PAIN LOWER 54 0.0021
859 ABDOMINAL PAIN UPPER 437 0.0021
860 CHEST DISCOMFORT 217 0.0021
861 SENSORY DISTURBANCE 34 0.0021
862 INFLUENZA LIKE ILLNESS 174 0.0021
863 HYPERSENSITIVITY 392 0.0021
864 PAIN 1297 0.0021
865 CONVULSION 120 0.0021
866 OROPHARYNGEAL PAIN 194 0.0021
867 PSYCHOTIC DISORDER 61 0.0021
868 FOOT FRACTURE 39 0.0021
869 WEIGHT INCREASED 460 0.0021
870 SOMNOLENCE 413 0.0020
871 PSYCHOMOTOR HYPERACTIVITY 34 0.0020
872 MYALGIA 346 0.0020
873 RESPIRATORY ARREST 56 0.0020
874 VERTIGO 123 0.0020
875 HERNIA 39 0.0020
876 FEELING JITTERY 38 0.0020
877 HEART RATE DECREASED 70 0.0020
878 LOWER LIMB FRACTURE 38 0.0020
879 CHRONIC KIDNEY DISEASE 149 0.0020
880 WHEEZING 116 0.0020
881 BURNING SENSATION 137 0.0020
882 ERYTHEMA 401 0.0019
883 ACTIVITIES OF DAILY LIVING IMPAIRED 38 0.0019
884 LIMB INJURY 52 0.0019
885 HALLUCINATION 144 0.0019
886 POOR QUALITY SLEEP 41 0.0019
887 THIRST 34 0.0019
888 NEOPLASM MALIGNANT 127 0.0019
889 DYSARTHRIA 71 0.0019
890 LUNG NEOPLASM MALIGNANT 76 0.0018
891 BLOOD GLUCOSE ABNORMAL 34 0.0018
892 BLINDNESS 75 0.0018
893 DISTURBANCE IN ATTENTION 99 0.0018
894 APHASIA 55 0.0018
895 RENAL INJURY 54 0.0018
896 PELVIC PAIN 33 0.0018
897 SLEEP DISORDER 128 0.0018
898 FEELING COLD 50 0.0018
899 URTICARIA 300 0.0018
900 AMNESIA 116 0.0018
901 RETCHING 38 0.0018
902 JOINT INJURY 38 0.0018
903 MEMORY IMPAIRMENT 242 0.0018
904 HYPERHIDROSIS 226 0.0018
905 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 84 0.0017
906 DRY MOUTH 141 0.0017
907 ARTHRALGIA 719 0.0017
908 VISUAL IMPAIRMENT 214 0.0017
909 DRY SKIN 230 0.0017
910 NEPHROLITHIASIS 79 0.0017
911 LACTIC ACIDOSIS 55 0.0017
912 INJURY 118 0.0017
913 EYE PAIN 94 0.0017
914 OCULAR HYPERAEMIA 79 0.0017
915 FAECES DISCOLOURED 36 0.0017
916 BLISTER 93 0.0017
917 SNEEZING 37 0.0016
918 DRUG ADMINISTRATION ERROR 50 0.0016
919 HYPOTHYROIDISM 52 0.0016
920 MUSCULOSKELETAL STIFFNESS 141 0.0016
921 SEIZURE 185 0.0016
922 FEELING ABNORMAL 383 0.0016
923 ANAPHYLACTIC REACTION 88 0.0016
924 PALLOR 43 0.0016
925 DRUG INTERACTION 248 0.0016
926 RESTLESSNESS 57 0.0016
927 THERAPY INTERRUPTED 111 0.0016
928 DRUG DOSE OMISSION 255 0.0015
929 RHABDOMYOLYSIS 64 0.0015
930 INJECTION SITE PRURITUS 100 0.0015
931 HEART RATE INCREASED 147 0.0015
932 ROAD TRAFFIC ACCIDENT 62 0.0015
933 BLOOD PRESSURE INCREASED 226 0.0015
934 DEPRESSION 334 0.0015
935 HEART RATE IRREGULAR 33 0.0015
936 ALOPECIA 286 0.0015
937 PALPITATIONS 167 0.0014
938 MEDICATION ERROR 78 0.0014
939 HEADACHE 874 0.0014
940 BLOOD PRESSURE FLUCTUATION 33 0.0014
941 PROSTATE CANCER 110 0.0014
942 ANGIOEDEMA 60 0.0014
943 SPEECH DISORDER 71 0.0014
944 MOOD SWINGS 43 0.0013
945 INTENTIONAL PRODUCT MISUSE 118 0.0013
946 INCORRECT ROUTE OF DRUG ADMINISTRATION 48 0.0013
947 PRODUCT DOSE OMISSION ISSUE 394 0.0013
948 BLOOD GLUCOSE INCREASED 252 0.0013
949 MENTAL DISORDER 58 0.0013
950 NERVOUSNESS 69 0.0013
951 ANXIETY 374 0.0013
952 BLOOD CHOLESTEROL INCREASED 61 0.0013
953 ASTHMA 147 0.0013
954 ILLNESS 133 0.0013
955 BREAST CANCER 118 0.0013
956 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 37 0.0013
957 FEELING HOT 77 0.0013
958 DISCOMFORT 76 0.0012
959 NASAL CONGESTION 73 0.0012
960 EYE PRURITUS 41 0.0012
961 THROAT TIGHTNESS 33 0.0012
962 TYPE 2 DIABETES MELLITUS 41 0.0012
963 MOBILITY DECREASED 86 0.0012
964 SWOLLEN TONGUE 37 0.0012
965 DEPRESSED MOOD 61 0.0012
966 HOT FLUSH 85 0.0011
967 DRUG EFFECT DECREASED 59 0.0011
968 IRRITABILITY 65 0.0011
969 THERAPY CESSATION 55 0.0011
970 THROAT IRRITATION 48 0.0011
971 BLOOD GLUCOSE DECREASED 48 0.0010
972 DYSKINESIA 40 0.0010
973 THERAPEUTIC RESPONSE UNEXPECTED 44 0.0010
974 EYE IRRITATION 52 0.0009
975 ECZEMA 45 0.0009
976 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 152 0.0008
977 AGGRESSION 42 0.0008
978 SURGERY 48 0.0008
979 INJECTION SITE BRUISING 65 0.0008
980 FLUSHING 81 0.0008
981 MIGRAINE 71 0.0007
982 EMOTIONAL DISTRESS 89 0.0007
983 BLADDER CANCER 43 0.0007
984 INJECTION SITE SWELLING 52 0.0007
985 ILL-DEFINED DISORDER 41 0.0007
986 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 46 0.0006
987 SUICIDAL IDEATION 47 0.0005
988 INJECTION SITE PAIN 146 0.0005
989 DRUG ABUSE 38 0.0005
990 ACNE 33 0.0004
991 INCORRECT DOSE ADMINISTERED 97 0.0004
992 RHEUMATOID ARTHRITIS 48 0.0004
993 OVERDOSE 78 0.0004